Astellas Raises Offer For OSI Pharma To $4 Billion

Masafumi Nogimori, president and chief executive officer of Astellas Pharma Inc., speaks a news conference in Tokyo, Japan, on Monday, May 17, 2010. Astellas Pharma Inc. agreed to buy OSI Pharmaceuticals Inc. for $4 billion in cash, raising its original offer by 11 percent per share to gain its first marketed cancer drug and sales force in the U.S. Photographer: Tomohiro Ohsumi/Bloomberg via Getty Images
Masafumi Nogimori, president and chief executive officer of Astellas Pharma Inc., speaks a news conference in Tokyo, Japan, on Monday, May 17, 2010. Astellas Pharma Inc. agreed to buy OSI Pharmaceuticals Inc. for $4 billion in cash, raising its original offer by 11 percent per share to gain its first marketed cancer drug and sales force in the U.S. Photographer: Tomohiro Ohsumi/Bloomberg via Getty Images
Astellas Raises Offer For OSI Pharma To $4 Billion
PURCHASE A LICENSE
How can I use this image?
$499.00
USD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
99628888
Collection:
Bloomberg
Date created:
May 17, 2010
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
ASTELLAS OSI